Works matching IS 0008543X AND DT 2019 AND VI 125 AND IP 15

Results: 25
    1
    2
    3
    4
    5
    6
    7
    8

    Inotuzumab ozogamicin in combination with low‐intensity chemotherapy (mini‐HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome‐negative acute lymphoblastic leukemia: A propensity score analysis

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 15, p. 2579, doi. 10.1002/cncr.32139
    By:
    • Jabbour, Elias J.;
    • Sasaki, Koji;
    • Ravandi, Farhad;
    • Short, Nicholas J.;
    • Garcia‐Manero, Guillermo;
    • Daver, Naval;
    • Kadia, Tapan;
    • Konopleva, Marina;
    • Jain, Nitin;
    • Cortes, Jorge;
    • Issa, Ghayas C.;
    • Jacob, Jovitta;
    • Kwari, Monica;
    • Thompson, Philip;
    • Garris, Rebecca;
    • Pemmaraju, Naveen;
    • Yilmaz, Musa;
    • O'Brien, Susan M.;
    • Kantarjian, Hagop M.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

    Published in:
    2019
    By:
    • Patel, Shreyaskumar;
    • von Mehren, Margaret;
    • Reed, Damon R.;
    • Kaiser, Pamela;
    • Charlson, John;
    • Ryan, Christopher W.;
    • Rushing, Daniel;
    • Livingston, Michael;
    • Singh, Arun;
    • Seth, Rahul;
    • Forscher, Charles;
    • D'Amato, Gina;
    • Chawla, Sant P.;
    • McCarthy, Sharon;
    • Wang, George;
    • Parekh, Trilok;
    • Knoblauch, Roland;
    • Hensley, Martee L.;
    • Maki, Robert G.;
    • Demetri, George D.
    Publication type:
    journal article
    20

    Issue Information.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 15, p. 2515, doi. 10.1002/cncr.31615
    Publication type:
    Article
    21
    22
    23
    24
    25